Clal Biotechnology Industries (XTAE:CBI) Change In Payables And Accrued Expense : ₪0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Clal Biotechnology Industries Change In Payables And Accrued Expense?

Clal Biotechnology Industries's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was ₪0.00 Mil. It means Clal Biotechnology Industries's Accounts Payable & Accrued Expense stayed the same from Jun. 2023 to Dec. 2023 .

Clal Biotechnology Industries's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was ₪0.00 Mil. It means Clal Biotechnology Industries's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Clal Biotechnology Industries Change In Payables And Accrued Expense Historical Data

The historical data trend for Clal Biotechnology Industries's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clal Biotechnology Industries Change In Payables And Accrued Expense Chart

Clal Biotechnology Industries Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Clal Biotechnology Industries Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Clal Biotechnology Industries Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪0.00 Mil.

Clal Biotechnology Industries Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Clal Biotechnology Industries's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Clal Biotechnology Industries (XTAE:CBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clal Biotechnology Industries Ltd (XTAE:CBI) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Azrieli Center, Triangle Building, 45th Floor, Tel Aviv, ISR, 67023

Website

http://www.cbi.co.il

Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.